Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Hilton Lac-Leamy

14 nov 2024 7:30 a.m. - 15 nov 2024 4:10 p.m.

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Session 9 Plenary: AI: Investments and Future Outcomes

Session Chair(s)

Oxana  Iliach, PhD

Oxana Iliach, PhD

Senior Director Regulatory Strategy

Certara, Canada

Marcia  Sam

Marcia Sam

Senior Manager, Regulatory Affairs

Regeneron Canada Company, Canada

This session will provide an overview of Health Canada current view on use of AI and potential future outcomes.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe potential use of AI
  • Discuss investments in AI development
  • Explain latest Health Canada expectations for AI outcomes

Speaker(s)

Kelly  Robinson, MSc

AI: Regulatory Reflections

Kelly Robinson, MSc

Health Canada, Canada

Director General, Marketed Health Products Directorate

Myriam  Salem, MSc

PIC/S Working Group on AI: International Collaboration of Pharmacovigilance Inspectors

Myriam Salem, MSc

Health Canada, Canada

Good Pharmacovigilance Practices National Coordinator

James  Van Loon

Leveraging AI at Health Canada (HC)

James Van Loon

Health Canada, Canada

Chief Data Officer, Digital Transformation Branch

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.